BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Supply of Dalteparin Sodium and Tinzaparin Sodium to NHS Scotland.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| LEO Pharma | - | ~£2,170,115 estimated from lot values | 1 lot Tinzaparin Sodium | - |
| Pfizer Ltd | 00526209 | ~£8,379,000 estimated from lot values | 1 lot Dalteparin Sodium | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Hanover Communications International Limited (3 quarters) Ovid Consulting Ltd (3 quarters) Incisive Health Ltd (1 quarter) MHP Communications (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
This procurement was divided into 2 lots, each awarded separately. 2 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Dalteparin Sodium 780 days (≈2.1 yrs) | £8,379,000 £8,632,704 initial term | 1 single bid — no competition | Pfizer Ltd | complete |
| Lot 2 Tinzaparin Sodium 780 days (≈2.1 yrs) | £2,170,115 £2,437,568 initial term | 1 single bid — no competition | LEO Pharma | complete |
Weightings from the notice, applied to every lot.
Government spending data: These suppliers have received £205,888,548 in 73 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care, NHS England, Ministry of Defence (2019-01-21 to 2026-03-12).
Published by the buyer on this notice. Check the original notice — details change and are not updated here.